开发用于自然杀手细胞扩张的转基因料细胞
DA Yeon Lee1,2, Yeongrin Kim1,3, Jin Song Park1
1Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
Anticancer research
|August 30, 2023
概括
合成生物学创造了新的养细胞,可以显著扩展自然杀手 (NK) 细胞. 这些增强的NK细胞表现出强大的抗癌活性,为NK细胞治疗提供了有前途的工具.
科学领域:
- 免疫学 免疫学 免疫学
- 合成生物学 合成生物学
- 细胞疗法细胞疗法
背景情况:
- 自然杀手 (NK) 细胞对于天生的免疫力和癌症监测至关重要.
- 扩大高质量的NK细胞用于治疗应用仍然是一个挑战.
研究的目的:
- 使用合成生物学开发新型料细胞,以增强NK细胞扩张.
- 在激活,细胞毒性和CAR-NK细胞发育方面评估扩展NK细胞的疗效.
主要方法:
- 改造K562细胞以表达与膜结合的互白素-2 (mbIL2) 或互白素-13 (mbIL13).
- 与工程养细胞和控制K562细胞共同培养的初级人类NK细胞.
- 分析了NK细胞激活,受体表达 (NKG2D) 和对癌细胞系的细胞毒性活性.
- 使用扩展的NK细胞开发了抗CD19化学抗原受体 (CAR) -NK细胞.
主要成果:
- 工程料细胞 (K562-mbIL2/mbIL13) 显著增加了激活的人类NK细胞的数量.
- 扩张的NK细胞表现出丰富的NKG2D激活受体,并增强了癌细胞的溶解.
- 来自扩张的NK细胞的抗CD19CAR-NK细胞对CD19+癌细胞表现出强大的细胞毒性.
结论:
- 通过合成生物学开发的新型料细胞有效扩展功能NK细胞.
- 这些养细胞代表了推进基于NK细胞的免疫疗法的宝贵工具.
- 扩大的NK细胞显示出改善癌症治疗策略的潜力.
相关概念视频
00:53Transgenic Organisms
Overview
02:50Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...